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1035-220 Unexpected High Incidence of Serious Pacemaker 
Problems Detected by Pre-and Postoperative 
Interrogations: A Two-Year Experience
Marc A. Rozner, Janene Roberson, A Duyen Nguyen, University of Texas M D Anderson 
Cancer Center, Houston, TX
Background: ACC Guidelines for perioperative care of the pacemaker (PM) patient sug-
gest both pre- and post-operative interrogations. No systematic evaluation of this practice
has been performed.
Methods: With IRB approval, records from Jan, 2000 through Dec, 2001 were reviewed.
We evaluated compliance with nationally published follow-up guidelines at a patient's first
visit to the Pre-Anesthesia Clinic. If a PM was checked postoperatively, we also recorded
the incidence and type(s) of problems.
Results: We found 172 PM patients (224 visits) for 149 surgical- and 75 non-surgical
procedures.
Compliance with follow-up guidelines was poor (see Table). Intervention was required in
15.7% (27 / 172) of the 1st-visit patients. Problems included:
- battery depletion (9);
- inadequate pacing energy (10 [6 ventricular, 4 atrial]);
- improper sensing (4 [1 ventricular, 3 atrial]);
- other (9); and
- multiple problems (5).
In the 52 subsequent visits, one patient needed a PM replacement.
Postoperative checks revealed 1 device reset and 6 pacing threshold increases (5 ven-
tricular, 1 atrial) in 149 surgical cases.
Conclusion: Many of our patients had not undergone a timely or satisfactory evaluation
of their PM prior to their preanesthetic visit, and 15.7% required intervention prior to their
elective procedure. We also found a 4.7% incidence of postoperative PM problems.
These findings: 1) suggest that many PM patients could be at risk for perioperative prob-
lems; and 2) support ACC guidelines for perioperative PM care.
1035-221 Percutaneous Pacemaker Lead Extraction in the 
Presence of Intracardiac Mass: Transesophageal 
Echocardiographic Findings and Clinical Outcomes
John E. O'Mara, Yuka Endo, Stanislav Weiner, Kevin J. Ferrick, Jay N. Gross, Montefiore 
Medical Center and Albert Einstein College of Medicine, Bronx, NY
Background: The clinical safety of percutaneous lead extraction (PLE) with a vegetation
or intracardiac mass >1 cm in diameter has not been established.
Methods: The records of 108 consecutive patients considered high risk for PLE second-
ary to prolonged implant duration and comorbidity were reviewed. All patients underwent
transesophageal echocardiography (TEE)-guided extraction.
Results: Intracardiac masses were found by TEE in 18 cases. The indication for lead
extraction was bacteremia in 9, pocket infection without bacteremia in 7, and lead mal-
function in 2 cases. In one patient, TEE detected a 2.8 cm mass attached to the right
atrial aspect of the lead in the presence of a patent foramen ovale (PFO) with a signifi-
cant right-to-left shunt; PLE was aborted and the patient underwent surgical removal.
The mass sizes in the seventeen patients who underwent PLE were <1 cm in 2 patients,
>1 cm but <2 cm in 5 patients, and >2 cm in 6 patients (mass size data unavailable in 4
cases). In all but three cases, the mass was attached to the right atrial side of the lead. In
12 cases, the mass was not visualized after lead extraction, suggesting pulmonary
embolization, but no patient developed acute hemodynamic compromise. Only one
patient developed clinically apparent pulmonary embolism post-operatively, which was
confirmed by spiral computed tomography. The patient was managed medically and dis-
charged home in stable condition. A second patient required a thoracotomy because
severe fibrotic adhesions precluded successful PLE.
Conclusions: 1) Seventeen percent of this patient population, which included non-bac-
teremic patients, had TEE-detectable masses attached or proximate to the leads. 2) PLE
was performed safely in 17 patients with lead-associated masses, 11 of which were
>1cm in size, and only one patient developed limited clinical sequelae secondary to pul-
monary embolization. 3) TEE can identify cases where surgical explantation is prefera-
ble, such as a mass in the presence of a PFO with a significant right-to-left shunt.
1035-222 Local Velocity Estimation Analysis During Bipolar 
Single Site and Linear Triple Site Rapid Pacing in 
Canine Models: Implications for Antitachycardia Pacing
Kyungmoo Ryu, Raja N. Ghanem, Celeen M. Khrestian, Jayakumar Sahadevan, Parvin 
C. Dorostkar, Robert N. Goldstein, Albert L. Waldo, Case Western Reserve University, 
Cleveland, OH
In anisotropic tissue, nonuniform conduction may cause block or delay, providing a sub-
strate for the onset and maintenance of reentrant atrial arrhythmias. We tested the
hypothesis that bipolar, linear, triple site pacing on the right atrium will generate more uni-
form wave front propagation than bipolar, single site pacing, thereby, reducing or elimi-
nating conduction block or delay. Methods - 6 pericarditis dogs and 2 normal dogs were
studied. Three plunge wire electrode pairs were placed 5-7mm apart in a perpendicular
and a parallel configuration at the superior aspect of the crista terminalis. The center pair,
which remained in the same position for both linear configurations, was used for single
site pacing. Using these three electrode configurations, pacing was performed at 200 and
300ms cycle lengths (CLs) for 6 sec. During pacing, 404 unipolar atrial electrograms
were recorded simultaneously from electrode arrays placed epicardially on both atria.
Local conduction velocity vectors were computed for every site using an automated algo-
rithm and plotted in a velocity vector field in a space domain for one beat during each epi-
sode. A histogram of absolute velocity vector angles from the x-axis was plotted to
assess uniformity of wave front propagation. Results - Triple site pacing showed: (1) a
distribution of velocity vectors with more uniform magnitude and direction compared to
single site pacing; (2) a predominant absolute velocity vector angle, in contrast to single
site pacing which showed a scattered angle distribution; (3) the overall mean epicardial
speed of both triple site pacing configurations was faster than single site pacing for each
pacing CL in each dog. The local velocity vector field plot, the absolute velocity vector
angle histogram, and the overall mean epicardial speed demonstrated that triple site pac-
ing created more uniform linear propagation compared to single site pacing. Conclu-
sions – Both perpendicular and parallel linear triple site pacing created more uniform
propagation compared to single site pacing with less or no conduction block or delay.
These findings may help develop more effective and safer pacing techniques for termina-
tion and prevention of atrial arrhythmias.
1035-223 Magnetic Resonance Imaging of the Brain Can Be 
Safely Performed in Patients With Pacemakers
Shane M. Bailey, Nour M. Juratli, Paul M. Ruggieri, Janet K. Sparker, Patrick J. Tchou, 
Bruce L. Wilkoff, Cleveland Clinic Foundation, Cleveland, OH
Background: The safety of magnetic resonance imaging in patients with pacemakers is
not known. We reviewed the outcomes of a clinical protocol allowing PM patients to
undergo MRI.
Methods: Sixty brain MRI scans were performed on 46 patients using a novel protocol.
Dual chamber PM was present in 32 patients and single chamber PM in 14 patients.
Prior to the scan, lead configuration was programmed to bipolar. Asynchronous mode
was programmed for PM-dependent patients. Monitoring during MRI included observa-
tion and pulse oximetry. Pacemaker interrogation was performed immediately before,
immediately after, and 3 months after MRI. All studies were performed in the head coil of
a Siemens 1.5T MRI whole body scanner. Conventional spin echo and echo-planar imag-
ing (EPI) acquisitions were performed with parameters that held the whole body specific
absorption rate (SAR) constant between 1-2Watts/kg.
Results: Mean atrial capture thresholds before, immediately after and 3 months after MRI
scanning were 1.11V, 1.13V and 1.10V (p = NS), respectively. Mean ventricular capture
thresholds were 1.20V, 1.21V and 1.33V (p = NS), respectively. Mean atrial sensing
thresholds were 2.39mV, 2.17mV and 2.16mV (p = NS), respectively. Mean ventricular
sensing thresholds were 8.47mV, 8.93mV and 9.79mV (p = NS), respectively. Mean atrial
impedances were 593Ω, 609Ω and 556Ω (p = NS), respectively. Mean ventricular imped-
ances were 661Ω, 678Ω and 657Ω (p = NS), respectively. No changes were observed in
programming. No patient experienced any arrhythmia or symptoms.
Conclusion: Patients with pacemakers can safely undergo brain MRI imaging using this
systematic and specific approach. No deleterious effects on PM or lead function were
observed.
1035-224 Do Onset Mechanisms of Paroxysmal Atrial Fibrillation 
Influence the Arrhythmia Episode Duration in Patients 
With Dual Chamber Pacing? Relevance for Preventive 
Pacing Algorithms
Alexander Yang, Marc Hochhausler, Alexander Bitzen, Jan Schrickel, Osman Balta, 
Berndt Luderitz, Thorsten Lewalter, The VIP Study Group, University of Bonn, Bonn, 
Germany
Background: Pacing algorithms to prevent paroxysmal atrial fibrillation (PAF) are mainly
based on the suppression of premature atrial contractions (PAC’s). However, according
to studies based on the analysis of 24-hour Holter recordings more than half of all PAF
episodes may be initiated by a solitary PAC (“sudden onset”). The objective of this study
was to evaluate the incidence of sudden PAF onsets in a population of patients with dual
chamber pacing and to relate the pre-onset PAC activity to the PAF episode duration.
Methods: A total of 264 PAF episodes in 45 pacemaker patients (Selection series, Vita-
tron Medical BV, Dieren, NL, all PAF preventive algorithms programmed off) with a history
of PAF were included. The correct detection of PAF by the pacemaker diagnostic features
was manually verified by analysis of the detailed onset reports of each PAF episode,
including marker electrocardiograms. According to the PAC activity before PAF onset all
Compliance with Nationally Published Guidelines for Pacemaker Follow-up Care
Follow-up 
Guideline
Applied to Number of 
Patients 
Evaluated
Telephone Check 
Recommendations 
(number of patients, % of 
total)
Comprehensive In-Office 
Evaluation 
Recommendations (number 
of patients, % of total)
Compliant Noncom
pliant
No Data Complia
nt
Noncompl
iant
No 
Data
North 
American 
Society of 
Pacing and 
Electrophysio
logy 
(NASPE)
All Patients 172 104
(60.5%)
66
(38.4%)
2
(1.2%)
111
(64.5%)
56
(32.6%)
5
(2.9%)
NASPE Any patient 
with an 
older 
device at 
"Intensified 
Follow-up 
Interval"
44 12
(27.3%)
32
(72.7%)
0 21
(47.7%)
20
(45.5%)
3
(6.8%)
Medicare Any patient 
over 65 
years of 
age
143 72
(50.3%)
69
(48.3%)
2
(1.4%)
76
(53.1%)
62
(43.4%)
5
(3.5%)
